We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
104 hedge funds and large institutions have $261M invested in Amphastar Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
88% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 25
55% more capital invested
Capital invested by funds: $168M → $261M (+$92.6M)
9% more funds holding
Funds holding: 95 → 104 (+9)
Holders
104
Holders Change
+9
Holders Change %
+9.47%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
47
Reduced
25
Closed
8
Calls
$691K
Puts
–
Net Calls
+$691K
Net Calls Change
+$691K
Top Buyers
Top Sellers
| 1 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.45M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.29M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.26M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$1.01M |
| 5 |
State Street
Boston,
Massachusetts
|
-$632K |
